HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
NEWS CRUNCH
Highlights from the E&L China 2020 Conference

E&L China 2020 conference was a huge success and was held from 9-10 December 2020 in Shanghai, China. Leading E&L experts gathered at Hotel Indigo Shanghai Hongqiao to discuss regulatory landscape, advances in science and testing methods, the latest technological developments of E&L realm. This year's conference is a vital platform for industry stakeholders to share their latest findings, case studies and invaluable insights.

This year's E&L China is organized by Smithers Information and sponsored by Shanghai WEIPU, MERCK, Milestone, Waters, Pall, SCIEX, Sci-Tech Innovation, Saint-Gobain. As the Asia's leading forum dedicated to the E&L value chain, E&L China 2020 attracted an international audience that spans the entire E&L value chain, including toxicologist, chemistry scientist, R&D manager, senior engineer, E&L project specialist, senior consultant, technical manager and more from across the E&L realm.

Conference day one was hosted by Xiaojun Yang, Technical Director of Biomedical Technology Center at Shanghai WEIPU and Cheney Lin, BD Director at Milestone. Under the topics of "Global regulatory landscape and updates on E&L, Insights and perspectives from pharma and biotech companies, E&L in pharmaceutical packaging and drug delivery systems, E&L in single use systems", industry leading professionals gathered to provide attendees with an unparalleled mix of actionable insights, collaborative case studies, and leading panel discussions centered around the hottest topics, latest trends, and emerging developments in E&L realm.

Focusing on "Challenges in E&L profiling: identification, Safety assessments and toxicology, E&L in medical devices, From theory to practice: experimental designs for E&L studies and case studies, Materials and biomaterials", conference day two was hosted by Songping Liao, Site Leader at China R&D - Baxter Healthcare and Yi Sun, Vice President at HuiYu Pharmaceutical Packaging Technology Research Institute. Let's review this spectacular event!

2020 E&L China Speakers

From left: Xiaojun Yang, Technical Director of Biomedical Technology Center at Shanghai WEIPU, Weichun Yang, Director of R&D Analysis and Quality Control Department at STA Pharmaceutical, Queenie Gai, Global E&L Senior Consultant at Merck, Xiaoxia Ye, Senior Analytical Researcher at Huadong Medicine, Dongdi Sun, Director of Chemistry Laboratory, Medical Device Testing Center at WuXi AppTec, Lei Zhang, Physicochemical Analysis Director at Henlius, Xiaoxiang Li, Manager of Scientific Laboratory Service Validation at Pall Corporation, Hovery Yin, Extractables/Leachables Project Specialist at Sartorius, Songping Liao, Site Leader at China R&D-Baxter Healthcare, Cheney Lin, BD Director at Milestone, Haiyan Hong, R&D Manager at Saint-Gobain Life Sciences, Guangming Wu, Technical Customer Manager at SCHOTT, Wenjing Zhao, Chemistry Scientist at Medtronic, Yi Sun, Vice President at HuiYu Pharmaceutical Packaging Technology Research Institute, Hongyu Luo, Principle Scientist at Baxter, Lynn Xie, R&D Manager at Becton Dickinson, Fangfang Zhang, Senior Engineer at Shanghai Food and Drug Packaging Material Control Center, Lynn Yao, Scientific Affairs Manager at West Pharmaceutical Packaging China.

Many domestic speakers delivered wonderful speeches onsite and participants actively participated in Q&A sessions. High-calibre speakers from AstraZeneca, Intertek, Novo Nordisk, Smithers, U.S. FDA, Shandong Quality Inspection Center for Medical Devices made speeches remotely and brought expert insights, a deep understanding of the whole market.

Panel Session

From left: Weixing Yang, CTO at Qingdao Sci-Tech Innovation, Lei Zhang, Physicochemical Analysis Director at Henlius, Xiaoxia Ye, Senior Analytical Researcher at Huadong Medicine, Dongdi Sun, Director of Chemistry Laboratory, Medical Device Testing Center at WuXi AppTec, Xiaojun Yang, Technical Director of Biomedical Technology Center at Shanghai WEIPU.

The two-day event is packed full of leading content, including a panel discussing "Challenges and the future trend of E&L studies and global requirements". Our speakers shared challenges and the future trend of E&L studies and requirements, and comparison among different requirements globally.

2020 Delegates

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy